American depositary receipts of European stocks were trading 0.31% lower at 125.92 on the Bank of New York Mellon Europe ADR Index on Monday.
In continental Europe, the gainers were led by medical equipment maker Edap ( EDAP ) and telecommunications company Ericsson ( ERIC ), which climbed 4.4% and 1.8% respectively. They were followed by biotech firm Zealand Pharma ( ZEAL ) and telecommunications operator Telecom Italia ( TI ), which rose 1.6% and 0.8%.
The decliners in continental Europe were led by furniture maker Natuzzi ( NTZ ) and pharmaceutical company Oasmia Pharmaceutical (OASM), which fell 4.1% and 2.8% respectively. They were followed by biotech company Forward Pharma (FWP) and internet advertising company Criteo (CRTO), which were off 2.6% and 2.5%.
In the UK and Ireland, the gainers were led by biopharmaceutical company NuCana (NCNA) and airline operator Ryanair (RYAAY), which rose 5.3% and 2% respectively. They were followed by biopharmaceutical firms Verona Pharma (VRNA) and Akari Therapeutics (AKTX), which were up 1.6% and 1.5%.
The decliners in the UK and Ireland were led by biopharmaceutical company Motif Bio (MTFB) and medical equipment maker Smith & Nephew (SNN), which lost 7.9% and 4.6% respectively. They were followed by pharmaceutical companies Avadel (AVDL) and GlaxoSmithKline (GSK), which were down 4% and 1.7%.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of NASDAQ, Inc.